Reuters logo
BRIEF-BioTime reports pro forma gain on deconsolidation of OncoCyte subsidiary
February 21, 2017 / 12:05 PM / 7 months ago

BRIEF-BioTime reports pro forma gain on deconsolidation of OncoCyte subsidiary

Feb 21 (Reuters) - BioTime Inc

* BioTime - Deconsolidation of Oncocyte’s financial’s from co’s consolidated financial statements; co to report pro forma non-cash gain of about $56 million

* BioTime Inc- amount of gain will be determined and recorded during quarter ending March 31, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below